Fig. 3. FOXO1 blocks neoplastic pathogenesis through multiple mechanisms in digestive malignancy.

FOXO1 upregulates the levels of caspase and downregulates the levels of Bcl-2. Moreover, FOXO1 blocks cell cycle progression, meanwhile suppressing angiogenesis and enhancing apoptosis.